Results 231 to 240 of about 39,387 (293)

Low Mean Corpuscular Hemoglobin Level is a Predictor of Discontinuation of Antiplatelet Therapy in Patients with Acute Coronary Syndrome

, 2011
Masaru Ishida, Hiroyuki Watanabe, Kenji Iino, Megumi Okawa, Toshimitsu Kosaka, Hiroshi Ito   +5 more
openalex   +2 more sources

Perinatal clinical management of a rare ABh variant blood group

Transfusion Medicine, EarlyView.
Abstract Background The H antigen, precursor of the A and B blood groups, is a high‐prevalence antigen. Very few H antigen‐negative (H−) blood donors are available in the United Kingdom. Case Presentation We present the case of a second pregnancy in a 28‐year‐old woman with the very rare ABh phenotype, and the presence of anti‐H, anti‐A and anti‐B ...
Aritri Mandal, Laura Eastwood, Shane Grimsley, Louise Tilley, Clare Samuelson   +4 more
wiley   +1 more source

The United Kingdom's largest experience with Contour in the treatment of wide-neck intracranial aneurysms with long-term (2-year) follow-up. [PDF]

Interv Neuroradiol
Islim FI, Suvarna R, Saleem N, Patankar T.   +3 more
europepmc   +1 more source

Influence of Antiplatelet Therapy on Cardiovascular Disease Prevention among Type 2 Diabetic Patients in Thailand

, 2019
Lampung Vonok, Somsak Pitaksanurat, Kritkantorn Suwannaphant, Teerasak Phajan, Wongsa Laohasiriwong   +4 more
openalex   +1 more source

An audit of platelet transfusions at a tertiary care center: New opportunities for patient blood management with the 2025 AABB/ICTMG platelet guidelines

Transfusion, EarlyView.
Abstract Background Platelet transfusions are an important tool to prevent and stop bleeding. Thresholds for pretransfusion platelet counts have been studied in various patient populations, yielding evidence‐based guidelines. The Association for the Advancement of Blood and Biotherapies (AABB) collaborated with the International Collaboration for ...
Rylee Yakymi, Claudia S. Cohn
wiley   +1 more source

Correction: The chemoprotective effect of anti-platelet agents on cancer incidence in people with non-alcoholic fatty liver disease (NAFLD): a retrospective cohort study. [PDF]

BMC Med
Anson M, Poon JS, Henney AE, Riley D, Ibarbaru GH, Sieberhagen C, Cuthbertson DJ, Alam U, Hydes T.   +8 more
europepmc   +1 more source

Ten-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with three-vessel disease and heart failure. [PDF]

Am Heart J Plus
Kang J, El-Andari R, Fialka N, Hong Y, McMurtry MS, Nagendran J, Nagendran J.   +6 more
europepmc   +1 more source

Laboratory Resistance to Antiplatelet Therapy as Part of Secondary Prevention After Atherothrombotic Stroke in the Early Recovery Period (On the Example of Clinical Cases)

Tatiana Yu. Batenkova
openalex   +2 more sources

Heat thermotherapy to improve cardiovascular function and cardiometabolic health: A systematic review and meta‐analysis

Experimental Physiology, EarlyView.
Abstract Heat thermotherapy (HT) is reported to promote cardiovascular (CV) and cardiometabolic health benefits. This systematic review and meta‐analysis (CRD42020193669) empirically investigated the efficacy of HT in improving CV and cardiometabolic parameters by assessing responses to single versus multiple HT bouts.
Ben S. Price, Samuel J. E. Lucas, Ashley P. Akerman, Rachel E. Gilworth, Rebekah A. I. Lucas   +4 more
wiley   +1 more source

The impact of chronic kidney disease on the antithrombotic strategies and outcomes in patients with acute coronary syndromes and atrial fibrillation: Insights from STAR-ACS study. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Yasuda K, Iwata H, Miyauchi K, Nojiri S, Nishizaki Y, Chikata Y, Minamino T, Daida H, STAR-ACS investigators.   +8 more
europepmc   +1 more source